Sudocetaxel Zendusortide (TH1902), a peptide-drug conjugate for the treatment of sortilin-positive (SORT1+) TNBC and Her2-positive breast cancers

被引:0
|
作者
Charfi, Cyndia
Demeule, Michel
Currie, Jean-Christophe
Zgheib, Alain
Danalache, Bogdan Alexandru
Beliveau, Richard
Marsolais, Christian
Annabi, Borhane
机构
关键词
D O I
10.1158/1538-7445.AM2023-4493
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4493
引用
收藏
页数:2
相关论文
共 44 条
  • [41] T-DM1 for HER2-positive metastatic breast cancer (MBC): Primary results from TH3RESA, a phase 3 study of T-DM1 vs treatment of physician's choice
    Wildiers, H.
    Kim, S. B.
    Gonzalez-Martin, A.
    LoRusso, P. M.
    Ferrero, J. M.
    Smitt, M.
    Yu, R.
    Leung, A.
    Krop, I. E.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S7 - S8
  • [42] Relationship between tumor biomarkers and efficacy in TH3RESA, a phase III study of trastuzumab emtansine (T-DM1) vs. treatment of physician's choice in previously treated HER2-positive advanced breast cancer
    Kim, Sung-Bae
    Wildiers, Hans
    Krop, Ian E.
    Smitt, Melanie
    Yu, Ron
    de Haas, Sanne Lysbet
    Gonzalez-Martin, Antonio
    INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (10) : 2336 - 2342
  • [43] Patient-reported outcomes (PkOs) from TH3RESA, a phase 3 study of trastuzumab emtansine, (T-DM1) versus treatment of physician's choice (TPC) in patients With pretreated HER2-positive advanced breast cancer.
    Bartley, Karen
    Wildiers, Hans
    Kim, Sung-Bae
    Krop, Ian E.
    Kang, Jennifer
    Yu, Ron
    Leung, Abraham C. F.
    Trudeau, Caroline
    Gonzalez-Martin, Antonio
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (26)
  • [44] Relationship between tumor biomarkers (BM) and efficacy in TH3RESA, a phase 3 study of trastuzumab emtansine (T-DM1) versus treatment of physician's choice (TPC) in HER2-positive advanced breast cancer (BC) previously treated with trastuzumab and lapatinib.
    Kim, Sung-Bae
    Wildiers, Hans
    Krop, Ian E.
    Leung, Abraham C. F.
    Trudeau, Caroline
    Yu, Ron
    de Haas, Sanne
    Gonzalez-Martin, Antonio
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)